文献速递中医妇科中药与中成药合理使用

补肾活血方通过调节雌激素-孕激素信号及FGF2促蜕膜血管生成减少小鼠着床丢失

Bushen Huoxue Recipe Alleviates Implantation Loss in Mice by Enhancing Estrogen-Progesterone Signals and Promoting Decidual Angiogenesis Through FGF2 During Early Pregnancy.
PubMed 文献 · Front Pharmacol · 2018-05-15

本研究以控制性超促排卵小鼠为着床丢失模型,评价补肾活血方(BSHXR)对着床、蜕膜化、蜕膜血管生成及生殖结局的影响。结果显示BSHXR可调节血清雌激素和孕激素的超生理水平,作用于基质和上皮的雌激素与孕激素受体,并增强蜕膜血管窦折叠区FGF2表达,从而可能减少早期妊娠着床丢失,促进胎盘形成和胎儿存活。

要点

  • BSHXR可调节超促排卵小鼠血清雌激素和孕激素的超生理水平。
  • BSHXR作用于基质和上皮的雌激素与孕激素受体。
  • BSHXR增强蜕膜血管窦折叠区FGF2表达,可能减少着床丢失。

核心结论

  • BSHXR通过调节雌激素-孕激素信号及增强蜕膜FGF2表达,可能减少小鼠早期妊娠着床丢失。

研究设计与样本

  • 采用控制性超促排卵小鼠作为着床丢失模型,评价BSHXR对着床、蜕膜化、蜕膜血管生成及生殖结局的影响。
  • BSHXR由黄芪、当归、川芎、菟丝子、桑寄生和续断六味中药组成。

主要发现

  • BSHXR可调节超促排卵小鼠血清雌激素和孕激素的超生理水平。
  • BSHXR作用于基质和上皮的雌激素与孕激素受体。
  • BSHXR增强蜕膜血管窦折叠区FGF2表达,可能减少着床丢失并促进胎盘形成和胎儿存活。

临床怎么用

  • 为BSHXR临床用于早期妊娠着床丢失提供科学依据,但需进一步研究验证其有效性和机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bushen Huoxue recipe (BSHXR) is a classic Chinese herbal prescription for nourishing the kidney and activating blood circulation. It consists of six herbs: Astragali radix, Angelicae sinensis radix, Ligustici Chuanxiong Rhizoma, Cuscutae semen, Taxilli Herba, and Dipsaci Radix, and the main active constituents of BSHXR are ferulic acid, calycosin-7-glucopyranoside, hyperoside, quercitrin, and asperosaponin VI. In clinical practice, BSHXR is traditionally used to treat failed pregnancy and its complications. However, little is known about the underlying mechanism of BSHXR for the treatment of implantation loss during early pregnancy. In the current study, controlled ovarian hyperstimulation was induced in mice as our implantation loss model, and we evaluated the effects of BSHXR on implantation, decidualization, decidual angiogenesis, and reproductive outcome. We showed that BSHXR could regulate the supraphysiological levels of serum estrogen and progesterone observed in these mice, and also act on estrogen and progesterone receptors in the stroma and epithelium. BSHXR also enhanced FGF2 expression in the vascular sinus folding area of the decidua, thus potentially reducing implantation loss during early pregnancy and contributing to placentation and survival of the fetuses. Taken together, our findings provide scientific evidence for the application of BSHXR in the clinic as a treatment for implantation loss during early pregnancy, and warrant further investigation of BSHXR as an effective treatment for failed pregnancy and its complications.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Ding J, Tan X, Song K, et al. Bushen Huoxue Recipe Alleviates Implantation Loss in Mice by Enhancing Estrogen-Progesterone Signals and Promoting Decidual Angiogenesis Through FGF2 During Early Pregnancy. Front Pharmacol. 2018. PMID: 29867455. doi:10.3389/fphar.2018.00437

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。